Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FMmeds vs Jently

FMmeds
Graded #261

Lower grade

vs+3.799999999999997
Jently
Graded #178

Higher grade

The verdict

Jently takes it — 67/100 to 63.2/100.

Jently grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Jently is a clinician-guided telehealth service offering compounded GLP-1 weight management (semaglutide from $149/mo, tirzepatide from $199/mo) alongside NAD+, peptide therapy (sermorelin, glutathione),…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJently +28
46
74
Dose & formulationFMmeds +8
72
64
Clinical oversightJently +9
70
79
Labs & monitoringFMmeds +1
53
52
FulfillmentFMmeds +30
97
67
Contract termsJently +4
47
51
FMmeds · left barJently · right bar

The numbers

MetricFMmedsJently
WeighScore63.2/10067/100
GradeCC
Scorecard rank#261#178
Semaglutide$225/mo (all doses, compounded)$149/mo (starting dose, compounded)
Tirzepatide$265/mo (all doses, compounded)$199/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
FMmeds

Graded #261 · C

Strengths

  • All 50 states plus DC covered, stated in the Terms
  • Operating LLC and full Manhattan Beach, CA address disclosed
  • Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
  • Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
  • Flat pricing across all dose strengths — no dose-escalation surcharge

Where it loses points

  • Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
  • Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
  • Clinical network not separately named
  • LegitScript Certified, but the specific ID isn't shown
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Jently

Graded #178 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
  • Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
  • 100% online with licensed providers via the MD Integrations network
  • Subscription can be cancelled anytime through the patient portal

Where it loses points

  • Specific pharmacy partner not named on the site
  • No refunds once a consultation is completed or a prescription is dispensed
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard